Annual Congress Berlin 2001

Saturday, 22.09.2001
Sunday, 23.09.2001
Monday, 24.09.2001
Tuesday, 25.09.2001
Wednesday, 26.09.2001

Citations should be made in the following way: Authors. Title. Eur Respir J 2004; 18: Suppl. 33, abstract number.

Material from 2001:

3025 Abstracts

Material from 2001: Show

Asthma

Oral Presentation
Chairs: J. Gerritsen (Groningen, The Netherlands), P. J. Helms (Aberdeen, UK)

Download all media

The novel dual D₂ dopamine receptor, β₂-adrenoceptor agonist, Viozan™ (AR-C68397AA) improves quality of life and perception of efficacy S. Wenzel, L. C. Laursen, L. Deamer, K. Rocchiccioli (Denver, United States Of America; Hellerup, Denmark; Charnwood, United Kingdom)
Asthma quality of life in clinical trials - can we combine data from different countries? E. Ståhl, D. S. Postma, E. F. Juniper, K. Svensson, C. G. Löfdahl (Lund, Sweden; Groningen, The Netherlands; Hamilton, Canada)
Airways' remodelling contributes to abnormal lung function and bronchial hyperresponsiveness during clinical remission of atopic asthma L. M. van den Toorn, S. E. Overbeek, J. B. Prins, H. C. Hoogsteden, J. C. de Jongste (Rotterdam, The Netherlands)
A self management plan increases satisfaction and reduces morbidity among adult patients one month after discharge L. M. Osman, C. Calder, J. A. Friend, J. S. Legge, J. G. Douglas (Aberdeen, United Kingdom)
Impact of nurse intervention on readmissions for asthma in adults P. T. White, A. Atherton, B. Birchall, L. Youlten (London, United Kingdom)
Reproducibility, reliability and diurnal variation of standardized exhaled NO measurements with NIOX™ in healthy and asthmatic children and adults made in routine clinical practice S. A. Kharitonov, F. Gonio, C. Kelly, S. Meah, P. J. Barnes (London, United Kingdom)
*Cost consequences of tiotropium plus existing therapy versus* existing therapy alone following one year of treatment in patients with COPD** M. Friedman, T. Bell, S. S. Menjoge, S. Anton, P. Koch (New Orleans, Research Triangle Park, Ridgefield, United States Of America)
Asthma and chronic idiopathic eosinophilic pneumonia (CIEP): a study of 52 patients E. Marchand, B. Etienne-Mastroianni, P. Chanez, D. Lauque, P. Leclerc, J. F. Cordier (Lyon, France)